Gilead Sciences (GILD) Fails to deliver data

Key failure to deliver metrics for Gilead Sciences:

• Last SEC data release: 2024-12-13
• Last 15 days FTD volume: NZ$2.2 M
• Last 3 months FTD volume: NZ$47.11 M
• Last year FTD volume: NZ$47.11 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Gilead Sciences (GILD) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Gilead Sciences (GILD) - since 2013

Gilead Sciences (GILD) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Amgen AMGN	NZ$32.27 M	NZ$0.25 B	🇺🇸 USA
Vertex Pharmaceuticals VRTX	NZ$19.65 M	NZ$44.75 M	🇺🇸 USA
AbbVie ABBV	NZ$87.11 M	NZ$0.18 B	🇺🇸 USA
Illumina ILMN	NZ$15.76 M	NZ$54.99 M	🇺🇸 USA
Biogen BIIB	NZ$24.89 M	NZ$68.31 M	🇺🇸 USA
Pfizer PFE	NZ$46.85 M	NZ$0.35 B	🇺🇸 USA
Johnson & Johnson JNJ	NZ$71.45 M	NZ$0.33 B	🇺🇸 USA
Eli Lilly LLY	NZ$76.19 M	NZ$0.17 B	🇺🇸 USA
Merck MRK	NZ$26.45 M	NZ$97.06 M	🇺🇸 USA